Loring Wolcott Coolidge Fa »

Amylyx Pharmaceuticals shares owned by Loring Wolcott Coolidge Fa

Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by Loring Wolcott Coolidge Fa from 13F filings

Historical chart of Loring Wolcott Coolidge Fa investment in Amylyx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amylyx Pharmaceuticals held by Loring Wolcott Coolidge Fa consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amylyx Pharmaceuticals by Loring Wolcott Coolidge Fa

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.6k 1.8k 1.98
2023-12-31 $29k 1.8k 16.00
2023-09-30 $33k 1.8k 18.02
2023-06-30 $39k 1.8k 21.57
2022-09-30 $51k 1.8k 28.29

More positions owned by Loring Wolcott Coolidge Fa

Microsoft Corp Common Stock (MSFT)
Mastercard Common Stock (MA)
Intuit Common Stock (INTU)
Alphabet Common Stock (GOOGL)
Fiserv Common Stock (FI)
Stryker Corp Common Stock (SYK)
Danaher Corp Shs Ben Int Common Stock (DHR)
Amazon.com Common Stock (AMZN)
Thermo Fisher Scientific Common Stock (TMO)
Adobe Systems Common Stock (ADBE)
Apple Common Stock (AAPL)
American Tower Corp Common Stock (AMT)
Tjx Companies Common Stock (TJX)
Nxp Semiconductors Foreign Stock (NXPI)
Servicenow Common Stock (NOW)

View all positions for Loring Wolcott Coolidge Fa

Top funds holding Amylyx Pharmaceuticals

Vanguard Group
Viking Global Investors
Point72 Asset Management
Millennium Management
Citadel Advisors
Ikarian Capital
Perceptive Advisors
Franklin Resources
Goldman Sachs Group
Jane Street
Eventide Asset Management
Jupiter Asset Management
Marshall Wace
T. Rowe Price Associates
Deutsche Bank Aktiengesellschaft

View all funds holding Amylyx Pharmaceuticals